Validation and Reliability of the Indonesian PDQ-39 Questionnaire in Parkinson?s Disease Patients
DOI:
https://doi.org/10.5614/api.v50i2.25127Keywords:
PDQ-39, validity, reliability, parkinsonAbstract
The PDQ-39 questionnaire is a disease-specific instrument used to measure the health-related quality of life (HRQoL) in Parkinson's disease patients. HRQoL assessment is one of key parameter for evaluating patient outcomes after receiving pharmacological and non-pharmacological treatments. The PDQ-39 questionnaire has been widely used in various countries, including Indonesia. However, no studies about validating and assessing the reliability of the Indonesian version of the PDQ-39 questionnaire have been published. This study aims to evaluate the validity and reliability of the Indonesian version of the PDQ-39 questionnaire. A cross-sectional study was conducted using a consecutive sampling technique. The study began with a language adaptation process. Questionnaire validity was assessed using Pearson?s Product-Moment correlation, while reliability was tested using Cronbach?s Alpha coefficient (>0.6). The questionnaire was administered to 31 outpatients at the Neurology Clinic of RSUD Arifin Achmad, Riau Province, and RSAU Dr. M. Salamun Bandung. Validity testing demonstrated that most correlation coefficients (r) between domains were acceptable (0.470?0.892) and statistically significant at p<0.01, except for item number twenty (r=0.345). Reliability testing showed a high overall Cronbach?s Alpha value of 0.924. Based on these findings, the Indonesian version of the PDQ-39 questionnaire is a valid and reliable instrument for measuring the quality of life in Parkinson's disease patients.
References
Aggarwal, R., Goyal, V., Pandey, R.M., Kumar, N., Singh, S., Shukla, G., Behari, M., 2020. Development and validation of quality of life in Parkinson?s disease instrument. Ann Indian Acad Neurol 23, 59?71. https://doi.org/10.4103/AIAN.AIAN_471_18
Ahmed, I., Sundas, I., 2021. Reliability and Validity: Importance in medical research. J Pak Med Assoc 71. https://doi.org/https://doi.org/10.47391/JPMA.06-861
Azaiez, C., Chalghaf, N., Ghalmi, I., Boussayala, G., Alajjouri, M.H.I., El-Sadoon, N.M., Al-Saadi, A.I.A.W., Lami, M.I., ben Chida Jammoussi, A., ben Ayed, C., Dergaa, I., Azaiez, F., 2024. Validating the Parkinson?s Disease Questionnaire (PDQ-39) in the Arab context: a pilot study among Tunisian patients. Cogent Psychol 11, 2418144. https://doi.org/10.1080/23311908.2024.2418144/ASSET/58FE4B48-1DF6-4DF6-B6AC-620B03E3950A/ASSETS/GRAPHIC/OAPS_A_2418144_F0002_B.JPG
Ben-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., Marras, C., San Luciano, M., Tanner, C., 2024. The epidemiology of Parkinson?s disease. The Lancet 403, 283?292. https://doi.org/10.1016/S0140-6736(23)01419-8/ASSET/D1BC9AFC-E8E2-4BC4-810B-59150A4043E4/MAIN.ASSETS/GR2.SML
Berardi, A., Regoli, E., Tofani, M., Valente, D., Fabbrini, G., Fabbrini, A., Ruggieri, M., Panuccio, F., Galeoto, G., 2021. Tools to assess the quality of life in patients with Parkinson?s disease: a systematic review. Expert Rev Pharmacoecon Outcomes Res 21, 55?68. https://doi.org/10.1080/14737167.2021.1841638
Bilge, T.K., Dereli, E.E., Oztop-Cakma, O., Ertan, F.S., Kayapinar Aylak, E.E., Taskiran, O.O., 2023. Reliability and validity of the Turkish version of the 39-item Parkinson Disease Questionnaire. Ideggyogy Sz 76, 181. https://doi.org/10.18071/ISZ.76.0181
Bloem, B.R., Okun, M.S., Klein, C., 2021. Parkinson?s disease. The Lancet 397, 2284?2303. https://doi.org/10.1016/S0140-6736(21)00218-X
Cassidy, I., Doody, O., Richardson, M., Meskell, P., 2024. Quality of life and living with Parkinson?s disease: a qualitative exploration within an Irish context. BMC Neurol 24, 1?11. https://doi.org/10.1186/S12883-024-03769-Y/FIGURES/1
Dahlan, M.S., 2016. Besar Sampel dalam Penelitian Kedokteran dan Kesehatan, 4th ed. Epidemiologi Indonesia, Jakarta.
Galeoto, G., Colalelli, F., Massai, P., Berardi, A., Tofani, M., Pierantozzi, M., Servadio, A., Fabbrini, A., Fabbrini, G., 2018. Quality of life in Parkinson?s disease: Italian validation of the Parkinson?s Disease Questionnaire (PDQ-39-IT). Neurological Sciences 39, 1903?1909. https://doi.org/10.1007/S10072-018-3524-X/METRICS
Li, X., Chen, C., Pan, T., Zhou, X., Sun, X., Zhang, Z., Wu, D., Chen, X., 2024. Trends and hotspots in non-motor symptoms of Parkinson?s disease: a 10-year bibliometric analysis. Front Aging Neurosci 16, 1335550. https://doi.org/10.3389/FNAGI.2024.1335550/BIBTEX
Lussy Natalia Hendrik, 2013. Depresi Berkorelasi dengan Rendahnya Kualitas Hidup Penderita Parkinson. Universitas Udayana, Denpasar.
Raisa, N., Maziya, Y., Rahma, A., Harbiyanti, N.T., Kurniawan, S.N., 2024. Parkinson?s Disease Quality of Life: Disease Severity Outweighs Pain Impact. Jurnal Kesehatan Prima 18. https://doi.org/10.32.807/jkp.v18i2.1657
Swarjana, I.K., 2016. Statistik Kesehatan. Andi Offset, Yogyakarta.
Waldvogel, L., Toloraia, K., Fuhr, P., Gschwandtner, U., 2023. Comparison of two questionnaires (PDQ-39 and SEIQoL) for assessment of the quality of life in idiopathic Parkinson?s disease Abbreviations. https://doi.org/10.17352/apt.000049
World Health Organization, 2024. Global Health Estimates 2021: Disease burden by Cause, Age, Sex, by Country and by Region, 2000-2021. World Health Organization, Geneva.
World Health Organization, 2022. Launch of WHO?s Parkinson disease technical brief [WWW Document]. URL https://www.who.int/news/item/14-06-2022-launch-of-who-s-parkinson-disease-technical-brief (accessed 1.9.25).
World Health Organization, Our World in Data, 2024. ?Deaths from Parkinson?s disease? [dataset]. World Health Organization, ?Global Health Estimates? [original data] [WWW Document]. URL https://ourworldindata.org/grapher/deaths-from-parkinsons-disease-ghe (accessed 1.11.25).
Zhao, N., Yang, Y., Zhang, L., Zhang, Q., Balbuena, L., Ungvari, G.S., Zang, Y.F., Xiang, Y.T., 2021. Quality of life in Parkinson?s disease: A systematic review and meta-analysis of comparative studies. CNS Neurosci Ther 27, 270?279. https://doi.org/10.1111/CNS.13549
